Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Therapeutics Inc
(NQ:
APLT
)
6.340
+0.260 (+4.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023
September 06, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Applied Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 02, 2023
Via
Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
July 31, 2023
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.
Via
Benzinga
Applied Therapeutics Provides Regulatory Update on Galactosemia Program
July 25, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association
June 22, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society
June 15, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency
May 25, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports First Quarter 2023 Financial Results
May 11, 2023
From
Applied Therapeutics
Via
GlobeNewswire
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Why First Republic Bank Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 28, 2023
Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 268% to $3.42 after dropping around 8% on Thursday.
Via
Benzinga
Applied Therapeutics' Investigational Drug Shows Clinical Benefit In Rare Metabolic Disorder, Chalks Out FDA Submission Plans
April 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission
April 24, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
April 24, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
March 23, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 20, 2023
It's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement!
Via
InvestorPlace
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Applied Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 17, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 17, 2023
Via
Benzinga
Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
February 17, 2023
We're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy
February 16, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.